Neurogene Inc.
NGNE
$15.00
$1.9715.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -630.75% | 3.44% | |||
| Gross Profit | 630.75% | -9.89% | |||
| SG&A Expenses | 4.58% | 10.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.56% | 5.32% | |||
| Operating Income | 2.56% | -10.16% | |||
| Income Before Tax | 3.48% | -9.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.48% | -9.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.48% | -9.33% | |||
| EBIT | 2.56% | -10.16% | |||
| EBITDA | 2.62% | -10.64% | |||
| EPS Basic | 15.95% | -9.25% | |||
| Normalized Basic EPS | 15.52% | -9.25% | |||
| EPS Diluted | 15.77% | -9.25% | |||
| Normalized Diluted EPS | 15.52% | -9.25% | |||
| Average Basic Shares Outstanding | 14.84% | 0.07% | |||
| Average Diluted Shares Outstanding | 14.84% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||